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According to the  concept of immune surveillance,  a  major function of the immune 
system is the detection and elimination of nascent autochthonous tumors (1-3). There is 
considerable evidence that cellular immune responses evoked in mice by immunization 
with  allogeneic cells  (4-5)  and  with  virally infected  (6-10)  or chemically treated  (11) 
syngeneic cells are mainly directed against cell surface antigens coded for by the K and 
D  regions  of the  H-2  major  histocompatibility  complex  (MHC). 1 Immune  responses 
against  nascent tumors  might similarly involve recognition of altered  or derepressed 
products coded for by the MHC (12, 13). This possibility is supported by ongoing studies 
on the tumor-associated transplantation antigen (TATA) expressed by transplacentally 
induced lung tumors of C3HfeB/HeN mice. As reported elsewhere (14, 15), some of these 
tumors  grow  poorly  when  inoculated  into  syngeneic  mice  but  will  grow  readily  if 
transplanted to (C3HfeB/HeN × A)F~ mice.  The preferential growth in the F~ recipients 
occurs because the TATA responsible for syngeneic immunity is present  as a  normal 
tissue  antigen  in  strain  A  mice  and  in  its  F1  hybrids  (14-16). This  antigen  is  also 
expressed in normal tissues of C3H/HeN mice, the strain from which the C3HfeB/HeN 
strain was originally derived. 2 Genetic studies have indicated that, in strain A mice, the 
lung tumor-associated normal tissue  alloantigen  is coded  for by a  gene linked to the 
MHC  (16). The antigen is not expressed by normal tissues of either C57BL/6 or DBA/2 
mice although it can be demonstrated on a proportion of transplacentally induced lung 
tumors of these strains  (17). These observations suggest that a genetic locus associated 
with the MHC is subject to regulation and that in mouse strains in which this locus is 
normally repressed it may code for a TATA on chemically induced lung tumors. 
In the present study we have investigated the strain and tissue distribution 
of the  lung tumor-associated alloantigen.  The results  clearly implicate the K 
region of the MHC in controlling the expression of the alloantigen.  Expression 
of this  H-2K  region-coded  alloantigen  in  normal  tissues  does  not  correlate 
directly with susceptibility to the spontaneous development of lung tumors in 
mice. 
~Abbreviations used in this paper: C3H, C3H/HeN strain mice; C3Hf, C3HfeB/HeN strain mice; 
MHC, major histocompatibility complex; SE, standard error of  the mean; TATA, tumor-associated 
transplantation antigen. 
2  W. J.  Martin,  T.  G.  Gipson, M.  A.  Conliffe, W.  G.  Cotton, L.  F~  Dove, and J.  M.  Rice. 
Histocompatibility difference between C3HfeB/HeN and C3H/HeN mice. Manuscript submitted 
for publication. 
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Materials  and  Methods 
Mice.  Inbred strains of mice used in this study were obtained from the Animal Production 
Unit,  National  Institutes of Health,  The  Jackson  Laboratory,  Bar  Harbor,  Maine,  Dr.  Jack 
Stimpling, McLauglin Research Institute, Great Falls, Mont., Dr. David Sachs, National Cancer 
Institute, Bethesda, Md., and Dr.  M. Zalenski of the State University of New York. A detailed 
description of the derivation of the C3HfeB/HeN strain from the C3H/HeN strain will be provided 
elsewhere.  2 These strains will be subsequently referred to as C3Hf and C3H, respectively. 
Tumors.  The  lung  tumor  85  was  induced  by  the  transplacental  administration  of  the 
carcinogen 1-ethyl-l-nitroseurea to a  13-day-pregnant C3Hf mouse (0.5 ~m/g maternal body wt). 
The tumor was detected in a  1-yr-old offspring of the treated mouse. Fragments of this tumor 
were transplanted into groups of C3Hf and (C3Hf x  A)F~ recipients. The tumor grew only in the 
(C3Hf x  A)FI mice. The tumor grew progressively in these mice. The tumor also grew when 
transplanted to X-irradiated C3Hf mice. Lung tumor tissue derived from a tumor-inoculated X- 
irradiated C3Hf mouse was explanted to tissue culture. Tissue culture-derived cells readily form 
adenocarcinomas when transplanted into either (C3Hf x  A)F~ or C3H mice. 
Antitumor Immunization.  Tissue was removed from donor mice and cut into approximately 1- 
mm  3 fragments. Recipient mice were anesthetized and inoculated with two tissue fragments, one 
given subcutaneously and one given intraperitoneally. 
X-irradiation.  2 wk after immunization the mice received 400 rads whole body X-irradiation 
at a dose rate of 125 rads/min. Control mice were similarly X-irradiated. 24 h after X-irradiation, 
the mice were challenged intradermally with l0  S  tissue culture-derived lung tumor 85 cells. Tumor 
growth was determined during the ensuing 21  days and recorded as mean tumor diameter  -+ 
standard error (SE). 
Results 
Growth Characteristics of Lung Tumor 85.  We have previously shown that 
the  C3Hf mouse-derived  lung  tumor  85  does  not  grow  progressively  when 
inoculated  into  normal  C3Hf recipients  but  will  grow  progressively  when 
inoculated  into  either  (C3Hf  x  A)F1  hybrid  or  C3H recipients ~ (14-16).  The 
tumor will grow in sublethally X-irradiated C3Hf mice provided the mice were 
not specifically immunized against the lung tumor before X-irradiation.  Fig.  1 
depicts the characteristic growth of 105 lung tumor 85 cells inoculated intrader- 
mally into normal  C3Hf and C3H recipients.  In Fig.  2 the growth of the lung 
tumor in X-irradiated  C3Hf mice preimmunized  with lung tissue from either 
C3Hf,  A,  or  C3H  mice  is  illustrated.  The  tumor  grows  progressively  in  X- 
irradiated,  previously untreated  C3Hf mice  and  in  C3Hf mice preimmunized 
with syngeneic lung tissue.  Preimmunization  with lung tissue from C3H or A 
mice protects X-irradiated C3Hf mice from subsequent lung tumor 85 challenge. 
We have used this system to test the tissue distribution  and genetic origin of 
the antigen  that  induces radioresistant  immunity  in C3Hf mice against  lung 
tumor 85. 
Tissue  Distribution  of  Tumor-Associated  Alloantigen.  C3Hf  mice  were 
immunized with either lung, liver, or kidney tissue of strain A mice and with 
spleen cells of (C3Hf x  A)FI mice. The immunized mice were subsequently X- 
irradiated and challenged with 105 tumor 85 cells. The results recorded in Table 
I depict the mean diameter of tumors present in the mice 15 days after tumor 
inoculation.  All  the  tissues  of  strain  A  mice  tested  were  able  to  evoke 
radioresistant anti-lung tumor immunity in C3Hf mice. In other experiments it 
has been shown that these same tissues from C3H mice can similarly immunize 
C3Hf mice  against  tumor  85.  In  contrast,  no  tissue  tested  from  C3Hf mice 
provided anti-tumor protection (Table I). 20 
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Fro.  1.  Mean tumor diameter of lung tumor 85 inoculated intradermally into either C3H 
(O) or C3Hf (e) mice.  10  mice of each strain were used in this experiment. Each mouse 
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FIG.  2.  Mean  tumor  diameter  of lung tumor  85 inoculated  intradermally  into either 
normal  C3Hf  mice  (0)  or  X.irradiated  C3Hf  mice  either  not  preimmunized  (O)  or 
preimmunized  14 days before tumor challenge with lung tissue from C3Hf (A), C3H ([~),  or 
A  (El)  strain mice. Each mouse received 10  ~  lung tumor cells.  10 mice were used per group. 
Tumor-Associated  Alloantigen  on  Embryo  Tissue.  Lung  tumor  85  was 
induced by administering the carcinogen ethyl-nitrosourea during fetal devel- 
opment.  Experiments  were  therefore  performed to  determine  whether  the 
tumor-associated alloantigen might be normally expressed during embryonic 1366  H-2K  REGION  CODED  TUMOR  ANTIGEN 
TABLE  I 
Tissue Distribution  of Lung Tumor 85 Cross-Reactive Alloantigen in A and C3H 
Strain Mice 
Tissue used for immuni- 
Exp.  zation  Donor strain 
Tumor growth in X-irradiated C3Hf 
mice 
Tumor inci-  Mean tumor diame- 
dence  ter ± SE 
mrn 
1  None  -  8/8  6.4 ___ 0.4* 
Lung  A  1/8  0.5 ± 0.5 
Liver  A  1/8  0.6 ± 0.6 
Kidney  A  1/7  0.4 ± 0.4 
Spleen  (C3Hf × A)F1  0/7  0.0 
2  None  -  11/11  11.2 ± 0.5 
Lung  C3Hf  7/7  12.2 ± 1.3 
Liver  C3Hf  6/6  9.9 ± 0.6 
Kidney  C3Hf  6/6  12,0 ± 1.2 
Spleen  C3Hf  6/6  11.5 ___ 0,5 
3  None  -  6/6  12.2 ± 1.4 
Embryo (15 day)  C3H  0/10  0.0 
Embryo (15 day)  C3Hf  10/10  13.4 ± 0.8 
Embryo (11 day)  C3Hf  6/6  13.9 ± 1.0 
Embryo (18 day)  C3Hf  5/6  10.2 ± 2.4 
* Tumor growth in the experiment was recorded at day 15 after tumor challenge.  In all other 
experiments the tumor growth was recorded at 21 days after tumor challenge. 
development of C3Hf mice.  C3Hf mice were immunized with tissue fragments 
from 15-day embryos derived from pregnant C3Hf or C3H mice. The immunized 
mice were X-irradiated  and  challenged  with lung tumor 85  cells.  The data  in 
Table I (exp. 3) indicate that mice were protected by preimmunization with C3H 
embryo tissue,  but not by C3Hf-derived embryo tissue.  Tissue from 11- and 18- 
day  C3Hf embryos  similarly  failed  to  confer  effective  anti-tumor  immunity 
(Table I). 
Strain  Distribution  of  Tumor-Associated  Alloantigen.  C3Hf  mice  were 
immunized with normal liver tissue from a wide variety of mice of various MHC 
haplotypes. Mice that share the H-2 ~ haplotype with strain A  mice, or the H-2 k 
haplotype with  C3H mice,  induced  highly significant immunity  in  C3Hf mice 
(Table  II).  Liver  tissue  from  CBA  (532)  strain  mice  (H-2  k~  haplotype)  was 
similarly found to induce  anti-lung  tumor 85 immunity in  C3Hf mice.  Tissue 
from mice of other H-2  haplotypes tested failed to induce significant immunity 
in C3Hf mice (Table III). 
Linkage  of Gene Coding for Alloantigen  to K  Region of MHC.  As can be 
noted  in  Tables II and  III, the  alloantigen  is  expressed  in  liver tissue  of the 
congenic strains B10.A  (H-2 a) and B10.BR  (H-2 k) but not in liver tissue of B10 
congenic  mice  expressing  other  MHC  haplotypes.  Similarly,  the  gene  is  not 
expressed  in  C3H-derived mice whose  MHC  haplotype  is  different  from H-2 k 
(Table  III,  exp.  2).  The  gene  coding  for  the  expression  of the  alloantigen  is 
therefore linked to the MHC. The MHC is known to comprise at least six clearly 
definable regions, designated K, IA, IB, IC, S, and D. The origin of the K, IA, 
and IB  regions  of H-2"  and H-2 k mice  are  similar  and  are  designated k.  The T.  G.  GIPSON,  M.  IMAMURA,  M.  A.  CONLIFFE,  AND  W.  J.  MARTIN 
TABLE  I~ 
Strain Distribution of Lung Tumor 85 Cross-Reactive Alloantigen 
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Donor strain of tis-  MHC haplo- 
sue used for immu-  type of donor 
nization  strain 
Tumor growth in X-irradiated C3Hf 
mice 
Tumor inci-  Mean tumor diame- 
dence  ter at 21 days ±  SE 
rnm 
None  -  7/7  11.2  ±  0.9 
C3Hf  -  6/6  12.2  ±  1.3 
A  a  3/11  1.1  _+  0.6 
AL  a  1/8  0.5  ±  0.5 
B10.A  a  0/6  0.0 
C3H  k  2/8  2.0  ±  1.3 
CBA  k  1/8  0.7  ±  0.8 
ST/b  k  0/8  0.0 
RF  k  3/7  1.4  ±  0.6 
AKR  k  0/8  0.0 
C57BR  k  1/7  1.6  ±  1.7 
B10.BR  k  3/7  2.8  ±  1.0 
Ma/My  k  2/8  1.4  ±  0.9 
CBA(M523)  ka  0/8  0.0 
TABLE  IiI 
Strain Distribution of Lung Tumor 85 Cross-Reactive Alloantigen 
Exp. 
Dcnor strain  of  MHC  haplo- 
tissue  used for  type of  donor 
immunizaLion  strain 
Tumor growth in X-irradiated 
C3Hf mice 
Mean tumor di- 
Tumor in-  ameter at 21 days 
cidence 
±  SE 
trim 
1  None  -  11/11  11.7  _  0.5 
AKR  k  1/6  1.2  _  1.3 
B10  b  6/6  11.2  ±  0.9 
B10.RIII  r  7/7  11.2  --- 0.5 
B10.PL  u  5/5  10.1  ±  0.4 
B10.P  p  6/6  12.8  ±  0.4 
B10.HTG  g  7/7  11.9  ±  0.5 
B10.WB  ya  7/7  11.5  ±  0.6 
B10.M  f  7/7  12.3  ±  0.,7 
B10.Y  pa  6/6  11.2  ±  0.4 
B10.Q  q  7/7  11.3  ±  0.4 
B10.S  s  5/5  13.4  ±  0.6 
B]0.SM  v  5/6  11.0  ±  2.3 
A.CA  f  6/6  11.9  ±  0.9 
DBA/2  d  5/5  11.1  ±  0.8 
LG  df  9/9  12.2  ±  0.4 
SJL  s  6/6  9.6  __-  0.2 
SWR  q  8/8  12.8  ±  0.5 
2  None  -  8/8  9.6  ±  0.7 
C3H/He  k  1/7  1.4  ±  1.5 
C3H.NB  p  6/7  8.2  +__  2.3 
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TABLE IV 
Expression of Lung Tumor 85 Cross-Reactive Alloantigen  in Congenic- 
Resistant Recombinant Strains of Mice 
Exp. 
Donor strain of 
tissue used for 
immunization 
Origin of MHC 
regions of donor 
strain 
Tumor growth in X-irradiated 
C3Hf mice 
Mean tumor  Tumor  K  IA  IB  IC  S  D  diameter  at 21  incidence  days -  SE 
rflm 
1  None  -  9/9  14.2 _+ 0.7 
B10.A(1R)  k  k  k  d  d  b  0/7  0.0 
B10.A(2R)  k  k  k  d  d  b  0/7  0.0 
B10.A (3R)  b  b  b  d  d  d  11/11  12.1 _+ 1.2 
B10.A (4R)  k  k  b  b  b  b  0/10  0.0 
B10.A(5R)  b  b  b  d  d  d  7/7  14.3 +_ 0.9 
B10.A (15R)  k  k  k  d  d  b  0/6  0.0 
B10.A(18R)  b  b  b  b  b  d  7/7  12.9_+ 1.0 
2  None  -  5/5  12.9 +_ 0.2 
B10.AQR  q  k  k  d  d  d  7/7  11.6_+ 0.6 
A.TL  s  k  k  k  k  d  6/6  11.8_+ 0.7 
C3H.OH  d  d  d  d  d  k  8/8  11.4_ 0.4 
B10.BR  k  k  k  k  k  k  3/7  1.5_+ 0.7 
remaining regions (IC, S,  and D) have a  different origin and are designated d 
and k for H-2 a and H-2 k mice, respectively (18).  (The MHC regions of H-2 b mice, 
e.g.  B10,  are  each  designated  b.)  Because  H-2 a  and  H-2 k  mice  share  the 
alloantigen  cross-reactive  with  the  TATA of the  tumor  85,  the  genetic  locus 
coding for this antigen is presumably linked more closely to the K, IA,  and IB 
regions of the MHC than to the IC, S,  and D  regions. To define more precisely 
this linkage to the MHC, C3Hf mice were immunized with tissue from a variety 
of recombinant  mice  (19)  inheriting  various  regions  of the  H-2 ~  and  H-2 k 
haplotypes. It is apparent from Table IV that tissue from 1R,  2R,  4R,  and 15R 
mice conferred anti-tumor immunity. Mice preimmunized with tissue from the 
3R,  5R,  and  18R  recombinants  failed  to  achieve  effective  immunity  to  lung 
tumor  challenge.  Thus,  the  haplotypes common to  all  the  strains  conferring 
immunity are H-2K k and H-2IA ~. To further delineate the genetics of expression 
of the alloantigen, tissues were tested from two strains of mice that express the 
H-2IA k haplotype but not the H-2K k haplotype. As shown in Table IV (exp.  2) 
neither tissue  from A.TL (H-2K ~)  nor B10.AQR (Ho2K~)  mice  was capable  of 
inducing anti-lung tumor immunity in C3Hf mice. 
Tissues from each of the strains shown to induce radioresistant immunity in 
C3Hf  mice  were  similarly  tested  for  their  ability  to  induce  radioresistant 
immunity against the lung tumor 85 in C3H mice. As shown in Table V neither 
tissues  from  the  congenic  resistant  recombinant  strains  nor  tissues  from 
representative  H-2 k  or H-2 a haplotype  strains  conferred  effective  anti-tumor 
immunity in C3H mice. T.  G.  GIPSON~ M.  IMAMURA,  M.  A.  CONLIFFE~ AND  W.  J.  MARTIN  1369 
TABLE V 
Inabihty to Induce Radioresistant Anti-Lung Tumor 85 Immunity in C3H 
Mice  Using Tissue from Mice that Express the Lung Tumor-Associated 
Cross-Reactive Alloantigen 
Exp. 
Donor strain used 
to immunize C3H 
mice 
Origin of MHC 
regions of donor 
strains 
Tumor growth in X-irradiated 
C3H mice 
K  /A  /B  /C 
Proportion  Mean tumor 
S  D  of mice with  diameter at 21 
tumors  days ± SE 
mm 
None  -  7/7  14.0 ± 0.9 
B10.A(1R)  k  k  k  d  d  b  6/6  16.3 ±0.5 
B10.A(2R)  k  k  k  d  d  b  5/5  11.2 ± 1.3 
B10.A(4R)  k  k  b  b  b  b  6/6  14.25± 0.8 
B10.A(15R)  k  k  k  d  d  b  6/6  14.2±0.7 
None  -  15/15  14.0 ± 0.4 
AKR  k  k  k  k  k  k  10/10  13.8 ±  1.2 
ST  k  k  k  k  k  k  5/6  13.0± 2.6 
AL/N  k  k  k  d  d  d  9/9  13.4_+ 0.7 
Discussion 
The  results  presented  in  this  paper clearly indicate  that  C3Hf mice do  not 
normally express a  tissue alloantigen readily detectable in other mice of known 
H-2K k haplotype.  This  antigen  is,  however,  expressed  on  the  C3Hf mouse- 
derived lung tumor 85 and,  as reported elsewhere,  is also expressed on several 
additional  transplacentally  induced  lung  tumors  of C3Hf (15),  C57BL/6,  and 
DBA/2  mice  (17).  It is not expressed  in normal tissues of C57BL/6,  DBA/2,  or 
other strains of mice that do not possess the H-2K k haplotype. 
The induction  of anti-lung  tumor  immunity  in  C3Hf mice with  tissue  from 
B10.BR (kkkkkk) and B10.A(4R)  (kkbbbb) mice but not with tissue from either 
A.TL (skkkkd) or B10.AQR (qkkddd) mice indicates that the expression of the 
tumor cross-reactive normal tissue alloantigen is determined by a  gene that is 
either  within  the H-2K region  of the  MHC  or to the  lefL  of the H-2K region. 
Because  there  are  relatively few commonly occurring  genetic  markers to the 
left of the MHC, the precise location of crossing over in this region for many of 
the recombinant strains used is unknown (18, 19).  Very close linkage or identity 
of the  genes  coding  for the  lung  tumor-associated alloantigen  and  the  H-2K  k 
antigen is, however, supported by the detection of the tumor-associated antigen 
in H-2  k mice of diverse origins. Thus, although a common parental stock can~be 
identified  in  the  early derivation  of strains  C3H,  CBA,  and  A  mice,  no clear 
relationship exists between the  origin  of these strains  and either RF,  St/b,  or 
Ma/My strains (18). It is interesting that the normal H-2k-associated alloantigen 
is readily detected in CBA (532) strain mice. Mice of this strain appear to have 
deviated from normal  CBA mice in  their  expression of an H-2K region-coded 
antigen  (20).  The MHC haplotype of the strain has been designated H-2  k~ (21). 
Because  the  apparent  alteration  in  the H-2K region  of C3Hf mice is  distinct 1370  H-2K  REGION  CODED  TUMOR  ANTIGEN 
from that of CBA (532) mice and because the H-2 ka strain is the only previously 
described mutation in the H-2K region of H-2  ~ mice, we propose that the H-2 
haplotype of the C3Hf strain be provisionally designated H-2 kb. As with several 
of the known mutations in the H-2K  region of the MHC  (22), we have been 
unable to detect serological differences between the H-2K-coded antigen on C3H 
and C3Hf mice.  Thus spleen cells from both of these strains are comparably 
susceptible to lysis by antisera directed against the private specificity of the H- 
2Kk-coded antigen (unpublished observations). The known public specificities of 
the  H-2K  A molecule  are  unlikely to  be  involved because  mice  of the  H-2 r 
haplotype express the same K region-coded public H-2 specificities as H-2 k mice 
(18). Attempts to raise  antisera specific for a  H-2K  region-coded molecule by 
cross immunizing C3H and C3Hf mice have to date not been successful. These 
serological studies need to be  extended,  however,  before it can be  concluded 
that no serologically detectable difference exists between the H-2K molecule of 
C3H  and C3Hf mice.  The  more  crucial question of whether the lung tumor- 
associated  normal  tissue  alloantigen  is  an  antigenic  determinant  on  the 
serologically defined H-2K molecule or a  cell surface component distinct from 
the serologically defined H-2K-coded molecule must await detailed structural 
studies of the serologically defined H-2K-coded antigen of C3H and C3Hf mice. 
Similarly, it is premature to conclude whether the expression of  the alloantigen 
on the  lung tumor 85  is the result of derepression of a  genetic locus coding 
directly for the alloantigen or for an enzyme (e.g. a glycosyl transferase) or for 
some  other  entity  (e.g.  a  type  C  viral  antigen)  capable  of modifying the 
antigenicity of a preexisting cell surface component. Experimental resolution of 
these issues should provide important insights into the complexity of  the genetic 
regulation of expression of MHC-coded alloantigens. 
The  studies reported  in  this and  related papers  reflect an  attempt to  test 
experimentally whether  genetically determined tumor  susceptibility can  be 
correlated with the expression of specific alloantigens on normal tissues. It was 
reasoned that it was advantageous to the host that certain genetic loci coding 
for cell surface antigens be repressed in normal, but not in malignant, cells. 
Derepression  of  an  antigen  on  malignant  cells  would  enable  the  host  to 
challenge immunologically the aberrant cell.  Only in strains of mice that did 
not express the antigen in normal tissue could that antigen function as a target 
for  immune  surveillance  (3,  14). The  expression  of a  strain  A-associated 
alloantigen on  lung tumors  induced  in  C3Hf mice  was  consistent with  the 
hypothesis, because strain A mice are far more susceptible than C3Hf mice to 
the  development  of  spontaneously  occurring  lung  tumors  (3,  9,  21). This 
interpretation cannot, however, be reconciled with the evidence obtained in the 
studies presented in this paper. Thus, B10.A strain mice and most strains of H- 
2  k mice have a  low incidence of spontaneously occurring lung tumors (23 and 
unpublished observations).  Furthermore,  BALB/c mice,  which are  relatively 
susceptible to lung tumors  (23), do not express the lung tumor 85-associated 
aUoantigen in their normal tissue. Nevertheless, it is clear that transplancen- 
tally induced lung tumors may express foreign MHC-coded alloantigens which 
are highly immunogenic in syngeneic mice. Furthermore, although not neces- 
sarily MHC coded, the TATA on several methylcholanthrene-induced  sarcomas 
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alloantigens.  Possibly a  more meaningful  consideration  of the biological rele- 
vance of altered alloantigen expression to tumor susceptibility may be to relate 
genetic  resistance  to tumor  development with  the propensity  to  express  new 
MHC-coded alloantigens.  In  preliminary  studies  we have observed that  lung 
tissue derived from C3Hf mice 4 to 6 wk after ethyl nitrosourea administration 
was capable of immunizing C3Hf but not (C3Hf x  A)FI hybrid mice, against the 
lung  tumor  85.  It  will  be  of interest  to  pursue  these  studies  to  determine 
whether the lung tumor 85-associated antigen can be induced in other tissues of 
C3Hf mice after carcinogen administration,  and to compare strain A and B10.A 
mice for any carcinogen-induced  alteration  of lung tissue expression of the H- 
2K region-coded antigen. 
Another aspect of the studies reported in the paper relates to the now well- 
established finding that H-2K and H-2D region-coded antigens  determine the 
susceptibility  of virus-infected  target  cells  to  lysis  by  antiviral  cytotoxic  T 
lymphocytes. Thus H.2K and/or H-2D compatibility between cytotoxic T  lym- 
phocyte and virus-infected target cell is generally required for immune lysis to 
occur  (6-10).  Evidence  has  recently  been  reported  which  strongly  favors the 
notion that  cytotoxic T-lymphocyte recognition of MHC-coded antigens  occurs 
independently  from  recognition  of viral  antigens  (25).  The  phenomenon  of 
MHC-restricted lysis of viral-infected target cells is relevant to a consideration 
of whether immune surveillance occurs against altered MHC-coded antigens of 
tumors.  Presumably,  if immune  surveillance  against  tumors  is  achieved  by 
recognition  of altered  or derepressed  MHC-coded antigens,  clones of lympho- 
cytes bearing receptors for these new antigens would be selectively expanded in 
normal mice. Assuming lymphocytes possess two distinct sets of independently 
segregating  receptors  (25,  26),  it  would  follow  that  in  normal  mice  most 
lymphocytes bearing a receptor for any given antigen (e.g. viral antigen) would 
have  their  second  receptor  directed  against  an  altered  MHC-coded antigen. 
Optimal  lysis would be expected to occur when the viral-infected  target  cells 
were recognized  by lymphoid  cells bearing  one  set  of receptors  for the  viral 
antigen and the other set of receptors for the viral-induced altered MHC-coded 
antigen.  Thus,  the H-2K and/or H-2D  compatibility requirement  for immune 
lysis of viral-infected target cells could support the notion of anti-tumor immune 
surveillance, providing the same altered MHC-coded antigens specify anti-tumor 
and anti-viral immunity.  This possibility can be tested by determining whether 
viral infection of C3Hf-derived cell lines can cause the expression of the C3H- 
associated  alloantigen.  In  this  regard  it  is  interesting  that  Garrido  and  his 
colleagues  (27,  28)  have  demonstrated  foreign  H-2-1ike  specificities on tumor 
cells after vaccinia virus infection. More extensive studies are clearly needed to 
define fully the interrelationship  between anti-viral and anti-tumor immunity. 
The  C3Hf mouse lung  tumor model system described in  the  paper  should  be 
useful  in  this  endeavor  and  should  encourage  more  direct  studies  on  the 
regulation of MHC-coded antigen expression in other tumor systems. 
Summary 
Transplacental  induction of lung tumors in C3HfeB/HeN (C3Hf) strain mice 
can be readily achieved with the carcinogen  1-ethyl-l-nitrosourea.  Several of 
these tumors express, as a tumor-associated transplantation  antigen (TATA), a 1372  H-2K  REGION  CODED  TUMOR  ANTIGEN 
normal tissue  alloantigen present in strain  A  and  C3H/HeN  (C3H) mice.  In 
the present study it was shown that the tumor-associated alloantigen on the 
C3Hf-derived lung tumor 85 was present in all mice of  H-2  ~ and H-2  k haplotypes 
tested and in CBA (532) strain mice (H-2  k" haplotype). Studies using congenic- 
resistant  and  recombinant  strains  of mice  indicated  that  the  genetic  locus 
controlling the expression of this antigen was either within or to the left of the 
H-2K region of the major histocompatibility complex (MHC). Thus the antigen 
was  expressed in B10.A  (4R)  mice  (kkbbbb  MHC  haplotype) but not in B10 
(bbbbbb)  or B10.AQR mice (qkkddd).  The antigen was expressed in all tissues 
tested of C3H  and  A  strain  mice.  It  was  not detected on  any tissue  tested 
including embryo tissue of C3Hf mice or mice of MHC haplotype other than H- 
2 k or H-2  ~  . Because C3Hf strain mice were originally derived from C3H strain 
mice (H-2  ~), the MHC haplotype of  C3Hf mice has been provisionally designated 
H-2  kb.  The finding of a  tumor-associated change in the expression of a H-2K 
region-coded antigen is consistent with the concept that MHC-coded antigens 
may act as targets for immunological surveillance of tumors. 
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